PL348421A1 - Benzisoxazoles and phenones as α2 - Google Patents
Benzisoxazoles and phenones as α2Info
- Publication number
- PL348421A1 PL348421A1 PL99348421A PL34842199A PL348421A1 PL 348421 A1 PL348421 A1 PL 348421A1 PL 99348421 A PL99348421 A PL 99348421A PL 34842199 A PL34842199 A PL 34842199A PL 348421 A1 PL348421 A1 PL 348421A1
- Authority
- PL
- Poland
- Prior art keywords
- benzisoxazoles
- phenones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98204358 | 1998-12-21 | ||
| PCT/EP1999/010054 WO2000037466A1 (en) | 1998-12-21 | 1999-12-14 | BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL348421A1 true PL348421A1 (en) | 2002-05-20 |
| PL196958B1 PL196958B1 (en) | 2008-02-29 |
Family
ID=8234508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL348421A PL196958B1 (en) | 1998-12-21 | 1999-12-14 | Benzisoxazoles and phenones as alpha 2-antagonists process for their preparation and their use as well as pharmaceutical composition |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6576640B1 (en) |
| EP (1) | EP1140934B1 (en) |
| JP (1) | JP4717216B2 (en) |
| KR (2) | KR20060093139A (en) |
| CN (1) | CN1154646C (en) |
| AR (1) | AR021924A1 (en) |
| AT (1) | ATE251622T1 (en) |
| AU (1) | AU765751B2 (en) |
| BG (1) | BG65162B1 (en) |
| BR (1) | BR9916427A (en) |
| CA (1) | CA2355716C (en) |
| CZ (1) | CZ294532B6 (en) |
| DE (1) | DE69911995T2 (en) |
| EA (1) | EA003606B1 (en) |
| EE (1) | EE200100329A (en) |
| ES (1) | ES2209553T3 (en) |
| HK (1) | HK1045686B (en) |
| HR (1) | HRP20010444A2 (en) |
| HU (1) | HUP0104812A3 (en) |
| ID (1) | ID28967A (en) |
| IL (2) | IL143830A0 (en) |
| NO (1) | NO317892B1 (en) |
| NZ (1) | NZ511411A (en) |
| PL (1) | PL196958B1 (en) |
| SK (1) | SK285560B6 (en) |
| TR (1) | TR200101813T2 (en) |
| TW (1) | TWI229673B (en) |
| UA (1) | UA71938C2 (en) |
| WO (1) | WO2000037466A1 (en) |
| ZA (1) | ZA200105067B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04000036A (en) | 2001-07-05 | 2004-05-21 | Upjohn Co | (hetero) aryl substituted benzofurans as 5-ht ligands. |
| JP2005521728A (en) * | 2002-04-03 | 2005-07-21 | オリオン コーポレーション | Use of α2-adrenergic receptor antagonists for CNS-related diseases |
| KR20060135023A (en) * | 2004-04-12 | 2006-12-28 | 다이쇼 세이야꾸 가부시끼가이샤 | Cyclic amine compound |
| EA200800430A1 (en) * | 2005-07-28 | 2008-06-30 | Бристол-Маерс Сквибб Компани | SUBSTITUTED TETRAHYDRO-1H-PYRIDO [4.3, B] INDOLS AS AGONISTS AND ANTAGONISTS OF SEROTONIN RECEPTORS |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3382250A (en) * | 1966-12-07 | 1968-05-07 | Abbott Lab | Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles |
| US3419568A (en) * | 1966-12-07 | 1968-12-31 | Abbott Lab | Derivatives of 1,2,3,4-tetrahydro-5h-pyrido[4,3b]indoles |
| US3718657A (en) * | 1970-12-03 | 1973-02-27 | Abbott Lab | Certain-2-substituted-1,2,3,4-tetrahydro-beta or gamma carbolines |
| JPS4729395U (en) * | 1971-04-26 | 1972-12-04 | ||
| US4001263A (en) * | 1974-04-01 | 1977-01-04 | Pfizer Inc. | 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines |
| AR206812A1 (en) * | 1974-04-01 | 1976-08-23 | Pfizer | INTERMEDIARY COMPOUNDS OF AZACICLO (3,4-A) INDOLES 4- AND 5-PHENYL SUBSTITUTED UNPROVED OF THERAPEUTIC ACTIVITY |
| US4224329A (en) * | 1979-01-23 | 1980-09-23 | Pfizer Inc. | 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles |
| FR2570701B1 (en) * | 1984-09-27 | 1987-05-22 | Synthelabo | FURO (3,2-C) PYRIDINES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| DE3522959A1 (en) * | 1985-06-27 | 1987-01-08 | Merck Patent Gmbh | INDOLDER DERIVATIVES |
| EP0339959A3 (en) * | 1988-04-27 | 1991-03-20 | Glaxo Group Limited | Lactam derivatives |
| WO1994008040A1 (en) * | 1992-09-25 | 1994-04-14 | Synaptic Pharmaceutical Corporation | Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| US5508306A (en) * | 1992-11-13 | 1996-04-16 | Synaptic Pharmaceutical Corporation | Aromatic amine derivatives |
| US5403847A (en) | 1992-11-13 | 1995-04-04 | Synaptic Pharmaceutical Corporation | Use of α1C specific compounds to treat benign prostatic hyperlasia |
| UA52681C2 (en) | 1997-04-08 | 2003-01-15 | Янссен Фармацевтика Н.В. | Derivatives of 1,2,3,4-tetrahydro-benzofuro [3,2,-c] pyridine |
-
1999
- 1999-12-14 CA CA2355716A patent/CA2355716C/en not_active Expired - Fee Related
- 1999-12-14 EP EP99967955A patent/EP1140934B1/en not_active Expired - Lifetime
- 1999-12-14 AU AU24327/00A patent/AU765751B2/en not_active Ceased
- 1999-12-14 NZ NZ511411A patent/NZ511411A/en unknown
- 1999-12-14 KR KR1020067015507A patent/KR20060093139A/en not_active Application Discontinuation
- 1999-12-14 EA EA200100709A patent/EA003606B1/en not_active IP Right Cessation
- 1999-12-14 CN CNB998147095A patent/CN1154646C/en not_active Expired - Fee Related
- 1999-12-14 DE DE69911995T patent/DE69911995T2/en not_active Expired - Lifetime
- 1999-12-14 IL IL14383099A patent/IL143830A0/en active IP Right Grant
- 1999-12-14 AT AT99967955T patent/ATE251622T1/en not_active IP Right Cessation
- 1999-12-14 PL PL348421A patent/PL196958B1/en unknown
- 1999-12-14 TR TR2001/01813T patent/TR200101813T2/en unknown
- 1999-12-14 KR KR1020017004946A patent/KR100657540B1/en not_active IP Right Cessation
- 1999-12-14 UA UA2001064352A patent/UA71938C2/en unknown
- 1999-12-14 ID IDW00200101335A patent/ID28967A/en unknown
- 1999-12-14 ES ES99967955T patent/ES2209553T3/en not_active Expired - Lifetime
- 1999-12-14 HU HU0104812A patent/HUP0104812A3/en unknown
- 1999-12-14 JP JP2000589537A patent/JP4717216B2/en not_active Expired - Fee Related
- 1999-12-14 EE EEP200100329A patent/EE200100329A/en unknown
- 1999-12-14 SK SK858-2001A patent/SK285560B6/en unknown
- 1999-12-14 CZ CZ20012120A patent/CZ294532B6/en not_active IP Right Cessation
- 1999-12-14 WO PCT/EP1999/010054 patent/WO2000037466A1/en not_active Application Discontinuation
- 1999-12-14 US US09/868,756 patent/US6576640B1/en not_active Expired - Lifetime
- 1999-12-14 BR BR9916427-2A patent/BR9916427A/en not_active Application Discontinuation
- 1999-12-16 TW TW088122067A patent/TWI229673B/en not_active IP Right Cessation
- 1999-12-20 AR ARP990106577A patent/AR021924A1/en active IP Right Grant
-
2001
- 2001-05-18 BG BG105521A patent/BG65162B1/en unknown
- 2001-06-06 NO NO20012783A patent/NO317892B1/en unknown
- 2001-06-14 HR HR20010444A patent/HRP20010444A2/en not_active Application Discontinuation
- 2001-06-19 IL IL143830A patent/IL143830A/en not_active IP Right Cessation
- 2001-06-20 ZA ZA200105067A patent/ZA200105067B/en unknown
-
2002
- 2002-07-09 HK HK02105098.8A patent/HK1045686B/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0101696A3 (en) | Shampoo composition | |
| AU136994S (en) | Section | |
| EP1056456A4 (en) | R-lansoprazole compositions and methods | |
| IL137528A0 (en) | Aerators | |
| PL332616A1 (en) | Hydoxymethylhexanones as odorising and savourising agents | |
| EP1073333A4 (en) | S-rabeprazole compositions and methods | |
| GB9820874D0 (en) | Melt-mouldable composites | |
| SG82031A1 (en) | Polyolefin-based resin compositions and fabricated products produced therefrom | |
| PL348421A1 (en) | Benzisoxazoles and phenones as α2 | |
| HU9900892D0 (en) | Enclosed multiple-biofilter | |
| DE69902457D1 (en) | Halter | |
| HU9900891D0 (en) | Putrefy set | |
| EP1073332A4 (en) | R-rabeprazole compositions and methods | |
| GB2337240B (en) | Propulsion unit | |
| GB9814447D0 (en) | Sonobuoy | |
| GB2337526B (en) | Easy rockeries | |
| GB9823217D0 (en) | Quick quion | |
| TW361226U (en) | Slipproof chopping block | |
| AU136569S (en) | Clevis | |
| TW346913U (en) | Rapidly assembling-type chan-plate | |
| GB9807428D0 (en) | Resin composition | |
| AU139709S (en) | Mailbox | |
| AU138239S (en) | Mailbox | |
| GB9807319D0 (en) | Personal toothbrush system | |
| GB9906773D0 (en) | Burgular buster |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification |